Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
2.430
-0.020 (-0.82%)
Aug 7, 2025, 4:00 PM - Market closed
Longboard Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Revenue | 61 | 64.83 | 76.35 | 99.5 | 105.62 | 78.01 | Upgrade |
Revenue Growth (YoY) | -16.79% | -15.09% | -23.26% | -5.80% | 35.39% | -29.34% | Upgrade |
Cost of Revenue | 19.58 | 20.53 | 24.19 | 33.53 | 31.53 | 26.62 | Upgrade |
Gross Profit | 41.41 | 44.31 | 52.17 | 65.97 | 74.09 | 51.39 | Upgrade |
Selling, General & Admin | 63.91 | 64.8 | 72.28 | 89.89 | 81.99 | 74.11 | Upgrade |
Research & Development | 6.46 | 6.69 | 8.2 | 10.95 | 9.65 | 7.75 | Upgrade |
Operating Expenses | 70.37 | 71.49 | 80.48 | 100.85 | 91.64 | 81.87 | Upgrade |
Operating Income | -28.95 | -27.18 | -28.31 | -34.88 | -17.54 | -30.48 | Upgrade |
Interest Expense | -6.77 | -7.66 | -6.89 | -4.56 | -4.96 | -8.34 | Upgrade |
Currency Exchange Gain (Loss) | -1.69 | -2.14 | 0.3 | -3.39 | -2.56 | 0.07 | Upgrade |
Other Non Operating Income (Expenses) | -0.01 | 0.77 | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | -37.43 | -36.2 | -34.91 | -42.82 | -25.06 | -38.75 | Upgrade |
Impairment of Goodwill | - | - | - | - | - | -27.45 | Upgrade |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | -0.17 | -1.48 | -0.57 | -2.53 | Upgrade |
Other Unusual Items | -12.4 | -11.36 | -2.04 | - | 2.78 | -12.91 | Upgrade |
Pretax Income | -49.86 | -47.58 | -37.12 | -44.31 | -22.85 | -81.64 | Upgrade |
Income Tax Expense | -0.31 | -0.61 | -0.07 | -0.72 | -0.71 | 1.18 | Upgrade |
Earnings From Continuing Operations | -49.55 | -46.97 | -37.05 | -43.58 | -22.14 | -82.82 | Upgrade |
Minority Interest in Earnings | -0.02 | -0.03 | -0.2 | -0.12 | -0.87 | 1.11 | Upgrade |
Net Income | -49.57 | -47 | -37.25 | -43.7 | -23.01 | -81.71 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 3.56 | Upgrade |
Net Income to Common | -49.57 | -47 | -37.25 | -43.7 | -23.01 | -85.27 | Upgrade |
Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade |
Shares Change (YoY) | 21.55% | 21.32% | 36.06% | 21.12% | 48.71% | 330.04% | Upgrade |
EPS (Basic) | -71.57 | -71.21 | -68.47 | -109.30 | -69.72 | -384.14 | Upgrade |
EPS (Diluted) | -71.58 | -71.21 | -68.47 | -109.34 | -69.72 | -384.45 | Upgrade |
Free Cash Flow | -14.63 | -11.19 | -12.98 | -27.32 | -20.28 | -28.94 | Upgrade |
Free Cash Flow Per Share | -21.13 | -16.95 | -23.85 | -68.32 | -61.45 | -130.38 | Upgrade |
Gross Margin | 67.90% | 68.34% | 68.32% | 66.31% | 70.15% | 65.87% | Upgrade |
Operating Margin | -47.47% | -41.93% | -37.08% | -35.05% | -16.61% | -39.07% | Upgrade |
Profit Margin | -81.26% | -72.49% | -48.79% | -43.92% | -21.79% | -109.30% | Upgrade |
Free Cash Flow Margin | -23.99% | -17.26% | -16.99% | -27.45% | -19.20% | -37.10% | Upgrade |
EBITDA | -25.09 | -23.3 | -24.19 | -30.41 | -12.69 | -25.67 | Upgrade |
EBITDA Margin | -41.13% | -35.93% | -31.69% | -30.57% | -12.01% | -32.91% | Upgrade |
D&A For EBITDA | 3.86 | 3.89 | 4.12 | 4.46 | 4.85 | 4.8 | Upgrade |
EBIT | -28.95 | -27.18 | -28.31 | -34.88 | -17.54 | -30.48 | Upgrade |
EBIT Margin | -47.47% | -41.93% | -37.08% | -35.05% | -16.61% | -39.07% | Upgrade |
Revenue as Reported | 61 | 64.83 | 76.35 | 99.5 | 105.62 | 78.01 | Upgrade |
Advertising Expenses | - | 1.22 | 1.12 | 1.78 | 1.82 | 1.09 | Upgrade |
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.